DoP issues revised public procurement guidelines
The objective is to further encourage the 'Make in India' and promote the manufacturing and production of goods and services in…
Author
NSRT to start Phase II trial of Eflornithine granules to treat COVID-19 by early Jan 2021
The company aims to complete the study by March 2021
HMD gets WHO-PQS certification for 0.3 ml Kojak AD Syringe, required for Pfizer’s vaccine
The company supplies to the UN Agencies like UNICEF, UNOPS for and is also manufactures auto disable syringes for curative…
Wallace Pharma sets up R&D Centre in Goa
The facility will have a special focus on new drug delivery systems (NDDS)
Minister of Chemicals and Fertilisers encourages industry to avail Phase II PLI scheme benefits
The scheme will be designed to benefit MSMEs along with large players
Pharmexcil submits recommendations for Foreign Trade Policy 2020-2025 to Commerce Ministry
It has highlighted key challenges faced by the pharma industry which require course corrections for creating a holistic and a…
Container shortage are delay pharma exports, affect sector’s financial performance: Industry
Stakeholders request government authorities to intervene and work out a solution on priority
SEC asks Bharat Serums to revise phase I/II trial protocols for equine antiserum to treat COVID-19
The SEC has recommended grant of permission to conduct the clinical trial provided the company submits the revised clinical trial…
Pharma industry urges government to extend MEIS scheme till March 2021
Since April 2020, the Indian pharma industry is facing a challenge in availing the MEIS benefits
DoP asks NPPA to review, verify Bharat Serum and Vaccine’s request of revising ceiling price…
The company submitted its application expressing that the NPPA has erred in fixing the ceiling price of formulation
